Moderna Q3 EPS $0.38 Beats $(1.26) Estimate, Sales $1.313B Beat $885.051M Estimate

Moderna (NASDAQ:MRNA) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $(1.26) by 130.16 percent. This is a 174.51 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $1.313 billion which beat the analyst consensus estimate of $885.051 million by 48.35 percent. This is a 29.23 percent increase over sales of $1.016 billion the same period last year.